Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review

As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve. Inflammation and endothelial dysfunction, as th...

Full description

Bibliographic Details
Main Author:	AN Jingjing, WANG Xiaojuan, DENG Aiyun
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2023-03-01
Series:	Zhongguo quanke yixue
Subjects:	percutaneous coronary intervention\|in-stent restenosis\|drug-eluting stents\|epicardial adipose tissue\|coronary disease
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220453.pdf

Similar Items

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Clinical profile and angiographic patterns of patients undergoing treatment for in-stent restenosis and outcomes associated with the treatment
by: Shivanand Patil, et al.
Published: (2020-01-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China
by: Mingrui Li, et al.
Published: (2022-01-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
by: Yong Zhu, et al.
Published: (2021-07-01)

Additional ablation effect of low‐speed rotational atherectomy following high‐speed rotational atherectomy on early calcified in‐stent restenosis: A case report
by: Tomoyo Hamana, et al.
Published: (2021-07-01)

High coronary calcium score and post-procedural CK-MB are noninvasive predictors of coronary stent restenosis
by: Lee JB, et al.
Published: (2017-02-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
by: Xiaohang Yuan, et al.
Published: (2023-08-01)

Oral Health of Patients Undergoing Percutaneous Coronary Intervention—A Possible Link between Periodontal Disease and In-Stent Restenosis
by: Ferenc Tamás Nagy, et al.
Published: (2023-04-01)

A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients
by: Qiang Feng, et al.
Published: (2022-08-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
by: Feng Xie, et al.
Published: (2024-02-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017-12-01)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
by: Xiao Long Lin, et al.
Published: (2022-09-01)

Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis
by: Ayman Elbadawi, et al.
Published: (2023-07-01)

Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience
by: Anis Ghariani, et al.
Published: (2022-05-01)

Comparative efficacy of interventional therapies and devices for coronary in-stent restenosis: A systematic review and network meta-analysis of randomized controlled trials
by: Shitian Guo, et al.
Published: (2024-03-01)

Vascular Endothelial Growth Factor Genetic Variant is Associated with In-Stent Restenosis after Percutaneous Coronary Intervention
by: Saeedeh Asgarbeik, et al.
Published: (2022-07-01)

A tale of two in stent restenosis in same patient: Surprising findings from optical coherence tomography
by: Akshyaya Pradhan, et al.
Published: (2023-11-01)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
by: Gábor Csató, et al.
Published: (2022-07-01)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
by: Hyung Joon Joo, et al.
Published: (2018-06-01)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention
by: Hou L, et al.
Published: (2023-08-01)

Variables asociadas a reestenosis clínica en pacientes con intervencionismo coronario percutáneo con stent convencional. Variables related to clinic restenosis in patients after percutaneous coronary interventionism with conventional stent.
by: Liz Álvarez González, et al.
Published: (2011-01-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
by: Hongfei Xi, et al.
Published: (2023-03-01)

Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries
by: Sheehy Alexander, et al.
Published: (2012-06-01)

Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention
by: Lizhi Lv, et al.
Published: (2019-07-01)

Stent in Coronary Bifurcation
by: Chor-Cheung Frankie Tam, MBBS
Published: (2021-06-01)

The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting
by: Hajizadeh Reza, et al.
Published: (2017-12-01)

Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
by: Wojciech Wańha, et al.
Published: (2022-04-01)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: Long-term angiographic and clinical results
by: T A Batyraliev, et al.
Published: (2010-08-01)

Frequency of In-Stent Restenosis among Different 2nd/3rd Drug Eluting Stents in Patients Presenting with ACS/Angina at Trtiary Cradiac Care Centre
by: Shakir Ghaffar, et al.
Published: (2022-11-01)

Hypersensitivity and in-stent restenosis in coronary stent materials
by: Wansong Hu, et al.
Published: (2022-09-01)

Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents
by: Pierre Brami, et al.
Published: (2023-10-01)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
by: Jiqiang Guo, et al.
Published: (2022-05-01)

Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study
by: Ling Zhang, et al.
Published: (2021-09-01)